Blockchain Registration Transaction Record

VolitionRx Automates Pet Cancer Testing in Japan with Fujifilm Partnership

VolitionRx partners with Fujifilm to automate Nu.Q Vet Cancer Test in Japan, enabling faster results for 1,700+ veterinary hospitals and 7 million pet dogs through IDS i10 platform.

This development represents a significant advancement in veterinary medicine that directly impacts pet owners and the animal healthcare industry. For the millions of pet owners in Japan and potentially worldwide, automated cancer testing means faster, more reliable results for their beloved animals, potentially leading to earlier interventions and better outcomes. The automation of the Nu.Q Vet Cancer Test addresses a critical need in veterinary diagnostics where timely results can be life-saving. This innovation also demonstrates how medical technology developed for humans can be successfully adapted for veterinary use, creating synergies that benefit both fields. As pet healthcare becomes increasingly sophisticated and pet owners seek human-grade medical care for their animals, such advancements in diagnostic technology help bridge the gap between human and veterinary medicine, potentially extending and improving the quality of life for companion animals while supporting the growing demand for advanced veterinary services.